MD
Associate Professor, Hematology
Clinical Director of Cellular Therapy Program
Medical Director, Adult CAR-T
UNC-Chapel Hill
Clinical Research
Meet Natalie Grover
Area of Interest
My primary research interest is in novel therapies for the treatment of lymphoma. My particular focus is in cellular therapy including innovative approaches to chimeric antigen receptor T-cell (CAR-T) therapy, improving the efficacy of CAR-T cells, and management and prevention of unique toxicities associated with this treatment. My ultimate goal is to improve therapeutic options of lymphoma patients, while minimizing toxicities and maintaining their quality of life.
Awards and Honors
- Oncology K12 Grant, 2018
- ASCO/AACR Methods in Clinical Cancer Research Workshop, 2017
- Cancer Outcomes Research Program Travel Award, UNC Lineberger Comprehensive Cancer Center, 2015
- Department of Medicine Research Grant, University of Virginia, 2012
- Crile Research Fellowship, Case Western Reserve University, 2008
News and Stories
CAR-T therapy helps patient beat cancer
When standard treatment didn’t work to treat his diffuse large B-cell lymphoma, John Bell found successful treatment with CAR-T therapy.
UNC researchers present latest findings at American Society of Hematology Annual Meeting
Researchers from UNC Lineberger and UNC will present findings from studies, speak at scientific symposia and lead educational sessions at the 65th American Society of Hematology Annual Meeting.
